Theravance Biopharma (TBPH) Share-based Compensation (2013 - 2026)
Theravance Biopharma's Share-based Compensation came in at $5.99 million for Q2 2026, up 31.9% from $4.54 million a year earlier and up 33.0% from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Share-based Compensation (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Theravance Biopharma reported Share-based Compensation of $19.55 million, down 3.3% year-over-year; for FY2025, it came in at $18.48 million, down 13.6% from FY2024.
- Share-based Compensation has declined in each of the last five years, with a five-year compound annual growth rate of -21.7% (FY2020 to FY2025).
- Going back by year, Share-based Compensation was $21.39 million in FY2024 (-15.7%), $25.37 million in FY2023 (-36.1%), $39.73 million in FY2022 (-36.0%) and $62.06 million in FY2021 (-1.5%).
- The Q2 2026 figure represents the highest quarterly Share-based Compensation since Q3 2023.
- Year-over-year, Share-based Compensation increased in 1 of the last eight quarters, with an average decline of 6.2%.
- The fastest year-over-year change in Share-based Compensation over five years came in Q2 2026 (growth of 31.9%), and the weakest in Q4 2022 (a decline of 58.9%).
- Business Quant data shows TBPH's Share-based Compensation at $4.5 million (Q1 2026), $4.48 million (Q4 2025) and $4.58 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | 5.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.99 Mn |
| Mar 31, 2026 | 4.50 Mn |
| Dec 31, 2025 | 4.48 Mn |
| Sep 30, 2025 | 4.58 Mn |
| Jun 30, 2025 | 4.54 Mn |
| Mar 31, 2025 | 4.88 Mn |
| Dec 31, 2024 | 5.83 Mn |
| Sep 30, 2024 | 4.96 Mn |
| Jun 30, 2024 | 5.38 Mn |
| Mar 31, 2024 | 5.23 Mn |
| Dec 31, 2023 | 5.82 Mn |
| Sep 30, 2023 | 6.26 Mn |
| Jun 30, 2023 | 6.26 Mn |
| Mar 31, 2023 | 7.02 Mn |
| Dec 31, 2022 | 6.95 Mn |
| Sep 30, 2022 | 8.53 Mn |
| Jun 30, 2022 | 9.71 Mn |
| Mar 31, 2022 | 14.55 Mn |
| Dec 31, 2021 | 16.92 Mn |
| Sep 30, 2021 | 14.37 Mn |
API Access
Theravance Biopharma Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();